Walgreens #11275 Medicare Supplier Location: 4746 Twin City Hwy, Groves, Texas 77619 Phone: (409) 960-6394 |
News Archive
Low-dose aspirin as primary prevention did not appear to significantly reduce the risk of a combined end point of coronary, cerebrovascular and peripheral vascular events in patients with type 2 diabetes, according to a new study in JAMA.
A study led by UCLA tested a new performance intervention to help improve adherence to national guideline-recommended therapies for heart failure patients in an outpatient setting.
As a society, we have to make choices. Do we want our doctors to be well-qualified practitioners using their experience and judgment to help as many patients as they can? Or do we want detached, disenfranchised doctors looking to their next career while practicing medicine with the mentality of postal workers? (Soumi Eachempati 12/7).
Also in the news, the Supreme Court - especially after the recent health law decision - is an effective tool to rally fundraising among both Democrats and Republicans. Meanwhile, a defense policy expert suggests presidential candidates focus on long-term military mental health issues. Finally, The Wall Street Journal examines how health care is playing in the Montana Senate race, where candidates are sparring over who is soft on cancer.
Rheonix, Inc., developer of the Rheonix CARD system that provides a powerful microfluidic platform for the evolving molecular diagnostics industry, announced that on June 14, 2011 the U.S. Patent and Trademark Office will issue Patent Number 7,959,875, "Microfluidic Chips and Assay Systems," and on April 13, 2011 it allowed Patent Application Number 11/594,444, "Microfluidic Systems," to the Company.
› Verified 5 days ago